The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest in the Company’s equity, except to the extent that the reverse stock ...

Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it intends to effect a ...

Reverse Stock Split On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”).

Global Medical REIT Inc. Announces the Approval of a $50 Million Common Stock Repurchase Program and One-for-Five Reverse Stock Split ...

LanzaTech (LNZA) Global announced that it will implement a 1-for-100 reverse stock split of its issued and outstanding common stock, effective August 18, 2025 at 5:00 p.m. Eastern Time.

On August 7, 2025, Orion Energy Systems ‘ shareholders approved a 1-for-10 reverse stock split of the company’s common stock, which was implemented on August 22, 2025. This move, intended to ...

Urge Stockholders to Vote “AGAINST” Reverse Stock Split at Upcoming Special Meeting Call for Accountability Given Board’s Pattern of Disregarding Stockholders’ Will and Value-Destructive ...

The Reverse Stock Split and Authorized Share Reduction were previously approved by the Company's stockholders at a special meeting of stockholders held on August 18, 2025. The Reverse Stock Split ...

A reverse mortgage can provide financial breathing room in retirement, but only if you understand and are prepared to manage its biggest disadvantages.

One of the founders of the lender service provider Blueacorn has entered a guilty plea in a scheme to fraudulently obtain COVID relief money through the Paycheck Protection Program (PPP).

LanzaTech Global (LNZA) will carry out a 1-for-100 reverse stock split on August 18, 2025, along with changes to par value and authorized shares.

(RTTNews) - Salarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biopharmaceutical company, Thursday announced that it will implement a 1-for-15 reverse stock split effective August 15.